LY3143921 / Eli Lilly 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LY3143921 / Eli Lilly
CRUKD/17/004, NCT03096054: A CR-UK Phase I Trial of LY3143921

Active, not recruiting
1
69
Europe
LY3143921 hydrate
Cancer Research UK
A. Colorectal Cancer, B. High Grade Serous Ovarian Cancer, C. Non Small-cell Lung Cancer (squamous Cell Variant), D. Squamous Carcinoma of the Oesophagus, E. Squamous Carcinoma of the Head and Neck (HPV Negative), F. Urothelial Cancer, G. Breast Cancer (triple Negative Type), H. Pancreatic Cancer
02/27
02/27

Download Options